The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: tenofovir     Quarter: 2016Q3

Total Records: 439     Number of Pages: 22

DRUGNAME PT EventCount
TENOFOVIR DISOPROXIL FUMARATE. Laceration 2
TENOFOVIR DISOPROXIL FUMARATE. Liver injury 2
TENOFOVIR DISOPROXIL FUMARATE. Low birth weight baby 2
TENOFOVIR DISOPROXIL FUMARATE. Meningitis cryptococcal 2
TENOFOVIR DISOPROXIL FUMARATE. Mitochondrial toxicity 2
TENOFOVIR DISOPROXIL FUMARATE. Nausea 2
TENOFOVIR DISOPROXIL FUMARATE. Necrosis 2
TENOFOVIR DISOPROXIL FUMARATE. Neonatal respiratory distress syndrome 2
TENOFOVIR DISOPROXIL FUMARATE. Neonatal tachypnoea 2
TENOFOVIR DISOPROXIL FUMARATE. Oedema 2
TENOFOVIR DISOPROXIL FUMARATE. Oedema peripheral 2
TENOFOVIR DISOPROXIL FUMARATE. Oxygen supplementation 2
TENOFOVIR DISOPROXIL FUMARATE. Patent ductus arteriosus 2
TENOFOVIR DISOPROXIL FUMARATE. Premature baby 2
TENOFOVIR DISOPROXIL FUMARATE. Premature rupture of membranes 2
TENOFOVIR DISOPROXIL FUMARATE. Product supply issue 2
TENOFOVIR DISOPROXIL FUMARATE. Product use issue 2
TENOFOVIR DISOPROXIL FUMARATE. Progressive external ophthalmoplegia 2
TENOFOVIR DISOPROXIL FUMARATE. Prolonged rupture of membranes 2
TENOFOVIR DISOPROXIL FUMARATE. Prostatitis 2

Total Records: 439     Number of Pages: 22